Back to search

Management of pulmonary hypertension resulting from interstitial lung disease

Data up to Jan 2025

Published2003
Citations34
References15

Total Citations Per Year

Abstract

References (15)

Bosentan Therapy for Pulmonary Arterial Hypertension

2002 • 2,715 citations

Continuous Subcutaneous Infusion of Treprostinil, a Prostacyclin Analogue, in Patients with Pulmonary Arterial Hypertension

2002 • 1,382 citations

Continuous Intravenous Epoprostenol for Pulmonary Hypertension Due to the Scleroderma Spectrum of Disease

2000 • 1,051 citations

Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial

2002 • 763 citations

Inhaled Prostacyclin and Iloprost in Severe Pulmonary Hypertension Secondary to Lung Fibrosis

1999 • 399 citations

Signaling Molecules in Nonfamilial Pulmonary Hypertension

2003 • 397 citations

Severe Pulmonary Hypertension in Histiocytosis X

2000 • 250 citations

Vasoresponsiveness of Sarcoidosis-Associated Pulmonary Hypertension

2001 • 125 citations

Outcomes for Patients With Sarcoidosis Awaiting Lung Transplantation

2002 • 114 citations

Case Report: Vascular Sarcoidosis: A Rare Cause of Pulmonary Hypertension

1983 • 72 citations

Arterial endothelin-1 level in pulmonary emphysema and interstitial lung disease. Relation with pulmonary hypertension during exercise

1997 • 59 citations

Sarcoidosis and Reactive Pulmonary Hypertension

1985 • 49 citations

Outpatient inhaled nitric oxide in a patient with idiopathic pulmonary fibrosis: a bridge to lung transplantation

2001 • 34 citations

Sarcoidosis and reactive pulmonary hypertension

1985 • 8 citations

Effects of infusion of prostacyclin on anatomical intrapulmonary right to left shunt: a useful model of human hypoxic vasoconstriction?

1989 • 4 citations

Cited By (0)

Loading...
Management of pulmonary hypertension resulting from interstitial lung disease (2003) – Current Opinion in Pulmonary Medicine | Metascience Observatory Explorer